Skip to main content

Day: June 11, 2021

Alm. Brand A/S to acquire the Danish business of Codan Forsikring A/S

Company announcement no. 11/2021 Alm. Brand A/S to acquire the Danish business of Codan Forsikring A/S Alm. Brand A/S (“Alm. Brand”) is pleased to announce that it has entered into a binding agreement with Intact Financial Corporation (“Intact”) and Tryg A/S (“Tryg”), through their jointly-owned subsidiary Scandi JV Co 2 A/S (“Seller“), whereby Alm. Brand will acquire Codan Forsikring A/S’s (“Codan Forsikring”) Danish business (the “Acquisition”). The Acquisition is currently expected to complete during the first half of 2022 following the transfer by Intact and Tryg of the Danish business of Codan Forsikring into a Danish legal entity incorporated for such purpose (“Codan DK”). Chairman of the Board of Directors Jørgen Hesselbjerg Mikkelsen:“With the acquisition of Codan DK, the Board of Directors sets a clear strategic course,...

Continue reading

Sinch AB (publ): Share split in Sinch AB (publ)

Stockholm, Sweden – Sinch AB (publ) – XSTO: SINCH On 18 May 2021, the annual general meeting in Sinch AB (publ) resolved on a share split 10:1 whereby each share is divided into ten shares. The board of directors was authorized to determine the record date for the split of the company’s shares. The board of directors has determined that the record date for the split of the shares in Sinch AB (publ) will be 18 June 2021. The last day of trading in the company’s shares before the share split is 16 June 2021. The first day of trading in the company’s shares after the share split is 17 June 2021. Following the share split, the new ISIN code for the company’s shares will be SE0016101844. After the share split is completed, the number of shares in the company will increase from 72,267,211 shares to 722,672,110 shares and the quota value of...

Continue reading

Code Red, a GameSquare Esports Company, Awarded U.S. Polo Assn. Contract

TORONTO, June 11, 2021 (GLOBE NEWSWIRE) — GameSquare Esports Inc. (CSE: GSQ; FRA: 29Q1) (“GameSquare”, “GameSquare Esports” or the “Company”), an international gaming and esports company, is pleased to announce that its subsidiary, Code Red Esports Ltd. (“Code Red”), The Authentic Esports Agency, has been awarded a contract to provide esports consultancy services to U.S. Polo Assn., the official brand of the United States Polo Association (“USPA”). U.S. Polo Assn. offers apparel for men, women and children, as well as accessories, footwear, travel and home goods in 180 countries worldwide. Recently ranked the fifth largest sports licensor in License Global magazine’s 2020 list of “Top 150 Global Licensors,” U.S. Polo Assn. is named alongside such iconic sports brands as the National Football League, the National...

Continue reading

TG Therapeutics Announces Data from a Phase 1 Study Evaluating TG-1701 as a Monotherapy and as a Triple Combination with Ublituximab and UKONIQ® at the 2021 European Hematology Association Virtual Congress

NEW YORK, June 11, 2021 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced data from TG-1701, the Company’s investigational once-daily, oral BTK inhibitor, as a monotherapy and as a triple therapy in combination with ublituximab, the Company’s novel glycoengineered anti-CD20 monoclonal antibody, and UKONIQ® (umbralisib), the Company’s once-daily, inhibitor of PI3K-delta and CK1-epsilon in patients with front line or relapsed/refractory non-Hodgkin’s lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Data from this trial were made available on demand this morning during the 3032 European Hematology Association (EHA) Virtual Congress. The data presented today were previously presented at the American Society of Clinical Oncology (ASCO) annual meeting. PRESENTATION HIGHLIGHTS: Poster Presentation Title:...

Continue reading

Nobel29 Resources Corp. Provides Update on Algarrobo Copper-Gold Project, Chile

Figure 1Location of the Algarrobo IOCG Project.Figure 2Magnetic survey coverage of the Algarrobo ProjectFigure 3Strongly mineralized intercepts from the newly discovered Gloria mineralized trend (assays pending)TORONTO, June 11, 2021 (GLOBE NEWSWIRE) — Nobel29 Resources Corp. (TSX-V: NBLC) (the “Company” or “Nobel”) provides an update on the ongoing exploration program at the Algarrobo project in Chile (Figure 1) (the “Project” or the “Algarrobo Project”). The Company has completed 31 diamond drill holes to date, for which it has assays results for 12 drill holes on wide spaced target areas within the Algarrobo Project. In addition, the Company has received interpreted results for 3,733 line km of high-resolution magnetic survey data covering the Project, and this data indicates...

Continue reading

Equillium Announces Positive Topline Results from the EQUATE Study in First-line Treatment of Acute Graft-Versus-Host Disease

Itolizumab continues to demonstrate favorable safety and efficacy profile Rapid and durable responses resulted in clinically meaningful reduction in corticosteroid use Data support clinical advancement of itolizumab in first-line treatment of aGVHD Conference call today at 8:00 am eastern time LA JOLLA, Calif., June 11, 2021 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, today announced positive topline data from the Phase 1b EQUATE study in first-line acute graft-versus-host-disease (aGVHD). The EQUATE trial is evaluating itolizumab in severe aGVHD patients concomitant with standard of care, which is typically comprised of high dose corticosteroids. There are no approved treatments for this severe, life threatening...

Continue reading

Autolus Therapeutics Presents New Data on obe-cel in r/r Indolent B Cell Lymphomas and gives an update of obe-cel in r/r Adult ALL at the European Hematology Association Virtual Congress

Obe-cel achieves 100% complete remission rate in a cohort of indolent B Cell Non-Hodgkin lymphoma patients with excellent CAR T engraftment, expansion, and persistence No ICANS or high grade Cytokine Release Syndrome observed Durability of response in ALL patients continues to support potential for transformational therapy in adult ALL Conference Call to be held on Friday, June 11, 2021 at 8:30 am ET / 1:30 pm BST LONDON, June 11, 2021 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced a poster presentation related to AUTO1 (obecabtagene autoleucel, obe-cel) in relapsed / refractory (r/r) indolent B cell lymphomas (IBCL) and included an update of duration of response in r/r adult Acute Lymphoblastic Leukemia...

Continue reading

Enthusiast Gaming Announces Pricing of its Previously Announced Equity Offering

TORONTO, June 11, 2021 (GLOBE NEWSWIRE) — Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (NASDAQ: EGLX) (TSX: EGLX), a media and content platform for video game and esports fans to connect and engage, is pleased to announce that the Company has priced the offering (the “Offering”) at USD$5.75 per common share (the “Common Shares”) for aggregate gross proceeds to the Company of USD$46,000,000. In connection with the offering the Company has entered into an agreement with a syndicate of underwriters co-led by RBC Capital Markets and Canaccord Genuity (the “Lead Underwriters”) as joint lead bookrunning managers, with B. Riley Securities acting as joint bookrunner, and including Paradigm Capital Inc., Scotia Capital Inc., Alliance Global Partners, Colliers Securities LLC and Haywood Securities Inc., as co-managers...

Continue reading

Sale of Codan Denmark to Alm. Brand A/S

Tryg announces today that Scandi JV Co 2 A/S (a company owned 50/50 by Tryg A/S and the Intact group) has entered into a conditional share purchase agreement for the sale of Codan’s Danish business (“Codan Denmark”) to Alm. Brand A/S. The agreed cash purchase price is approximately DKK 12.6bn for 100% of the share capital of Codan Denmark. Tryg will receive 50% of the sale proceeds. The sale is expected to have a positive impact on Tryg’s previously disclosed expectation of an ROI of approximately 7% for the acquisition of RSA. The transaction is subject to, e.g., customary regulatory approvals from relevant authorities – including from the Danish Financial Supervisory Authority and the competition authorities – and completion by Alm. Brand A/S of an underwritten rights issue that is also supported by Alm....

Continue reading

Enterprise Governance, Risk, and Compliance Market to Hit USD 75.24 Billion by 2028; Industry Giants Such as IBM & SAP to Focus on Developing Advanced eGRC Systems for Large Organizations: Fortune Business Insights™

Key Companies Covered in eGRC Market Research Report are Origami Risk, Blue Umbrella Limited, Tevora, LogicManager, SAI Global, Software AG, BWise, Wolters Kluwer N.V., SAP SE , IBM Corporation, Riskonnect, Inc., OneTrust, LLC, Ideagen Plc, NAVEX Global, Inc., Dell Technologies, Infosys Limited, MetricStream Inc., Thomson Reuters Corporation, Microsoft Corporation, SAS . Pune, India, June 11, 2021 (GLOBE NEWSWIRE) — The global eGRC market size is projected to reach USD 75.24 billion by 2028, exhibiting a CAGR of 14.0% during the forecast period. Tightening compliance, risk, and governance mandates by regulatory authorities worldwide is expected to emerge as the foremost growth driver for this market, shares Fortune Business Insights™ in its report, titled “Enterprise Governance, Risk, and Compliance (eGRC) Market, 2021-2028”....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.